Presents guidelines presented by the Committee on Drugs of the American Academy of
Pediatrics for the ethical conduct of studies in evaluating drugs in pediatric populations.
Need to study drugs in children; Risk/benefit categories for children; Required contents of
written consent; Patients requiring emergency care; Payment for participation.